Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 28

1.

Neuropsychological profile in patients with obsessive-compulsive disorder over a period of 4-month treatment.

Kim MS, Park SJ, Shin MS, Kwon JS.

J Psychiatr Res. 2002 Jul-Aug;36(4):257-65.

PMID:
12191630
2.

[Value of fluoxetine in obsessive-compulsive disorder in the adult: review of the literature].

Etain B, Bonnet-Perrin E.

Encephale. 2001 May-Jun;27(3):280-9. Review. French.

PMID:
11488259
3.

[Pharmacologic treatment of obsessive compulsive disorder in the child and adolescent].

Flament MF.

Encephale. 1993 Mar-Apr;19(2):75-81. Review. French.

PMID:
8275900
4.

[Psychosurgical treatment of malignant OCD: three case-reports].

Polosan M, Millet B, Bougerol T, Olié JP, Devaux B.

Encephale. 2003 Nov-Dec;29(6):545-52. Review. French.

PMID:
15029089
5.

Neuropsychological performance in obsessive-compulsive disorder: a critical review.

Kuelz AK, Hohagen F, Voderholzer U.

Biol Psychol. 2004 Feb;65(3):185-236. Review.

PMID:
14757309
6.

[Critical analysis of controlled pharmacologic studies in obsessive compulsive disorder].

Brochier T, Hantouche E.

Encephale. 1989 May-Jun;15(3):325-33. Review. French.

PMID:
8641159
7.

Obsessive-compulsive disorder.

George MS.

Int Clin Psychopharmacol. 1991 Dec;6 Suppl 3:57-66; discussion 66-8. Review.

PMID:
1806635
8.
9.

Efficacy of treatments for patients with obsessive-compulsive disorder: a systematic review.

Choi YJ.

J Am Acad Nurse Pract. 2009 Apr;21(4):207-13. doi: 10.1111/j.1745-7599.2009.00408.x. Review.

PMID:
19366379
10.

A systematic review: antipsychotic augmentation with treatment refractory obsessive-compulsive disorder.

Bloch MH, Landeros-Weisenberger A, Kelmendi B, Coric V, Bracken MB, Leckman JF.

Mol Psychiatry. 2006 Jul;11(7):622-32. Epub 2006 Apr 4. Review. Erratum in: Mol Psychiatry. 2006 Aug;11(8):795.

PMID:
16585942
11.

[Neuropsychological profile of childhood-onset obsessive-compulsive disorder].

Irak M, Flament MF.

Turk Psikiyatri Derg. 2007 Winter;18(4):293-301. Review. Turkish.

12.

Management of treatment-refractory obsessive compulsive disorder patients.

Dominguez RA, Mestre SM.

J Clin Psychiatry. 1994 Oct;55 Suppl:86-92. Review.

PMID:
7961537
13.

Pharmacotherapy of obsessive-compulsive disorder.

Jermain DM, Crismon ML.

Pharmacotherapy. 1990;10(3):175-98. Review.

PMID:
2196535
14.

Pharmacotherapy of childhood obsessive-compulsive disorder.

Leonard HL, Rapoport JL.

Psychiatr Clin North Am. 1989 Dec;12(4):963-70. Review.

PMID:
2690035
15.

A risk-benefit assessment of drugs used in the management of obsessive-compulsive disorder.

Carpenter LL, McDougle CJ, Epperson CN, Price LH.

Drug Saf. 1996 Aug;15(2):116-34. Review.

PMID:
8884163
16.
17.

Pharmacologic treatment of obsessive compulsive disorders.

Jenike MA.

Psychiatr Clin North Am. 1992 Dec;15(4):895-919. Review.

PMID:
1461804
18.

[Drug treatment of obsessive-compulsive disorders--a comparative study of the effectiveness of clomipramine and fluoxetine].

Volk S.

Fortschr Neurol Psychiatr. 1995 Jun;63 Suppl 1:28-32. Review. German. No abstract available.

PMID:
7635392
19.

Deep brain stimulation for treatment refractory obsessive-compulsive disorder--a case report.

Csigó K, Dome L, Valálik I, Harsányi A, Demeter G, Racsmány M.

Ideggyogy Sz. 2010 Mar 30;63(3-4):137-42. Review. Erratum in: Ideggyogy Sz. 2010 Sep 30;63(9-10):327. Valálik, I [added].

PMID:
20405672
20.

Approaches to the patient with treatment-refractory obsessive compulsive disorder.

Jenike MA.

J Clin Psychiatry. 1990 Feb;51 Suppl:15-21. Review.

PMID:
2404966
Items per page

Supplemental Content

Write to the Help Desk